These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33639312)

  • 21. [Topical treatment of vaginal infections by the association of metronidazole-clotrimazole].
    Tavassoli K; Mattana P
    Minerva Ginecol; 2013 Dec; 65(6):707-15. PubMed ID: 24346255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin-Loaded Liquid Crystalline Systems for Controlled Drug Release and Improved Treatment of Vulvovaginal Candidiasis.
    Rodero CF; Fioramonti Calixto GM; Cristina Dos Santos K; Sato MR; Aparecido Dos Santos Ramos M; Miró MS; Rodríguez E; Vigezzi C; Bauab TM; Sotomayor CE; Chorilli M
    Mol Pharm; 2018 Oct; 15(10):4491-4504. PubMed ID: 30184431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development, characterization, and in vitro-in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis.
    Fernandes Costa A; Evangelista Araujo D; Santos Cabral M; Teles Brito I; Borges de Menezes Leite L; Pereira M; Correa Amaral A
    Med Mycol; 2019 Jan; 57(1):52-62. PubMed ID: 29361177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled-release biodegradable nanoparticles: From preparation to vaginal applications.
    Martínez-Pérez B; Quintanar-Guerrero D; Tapia-Tapia M; Cisneros-Tamayo R; Zambrano-Zaragoza ML; Alcalá-Alcalá S; Mendoza-Muñoz N; Piñón-Segundo E
    Eur J Pharm Sci; 2018 Mar; 115():185-195. PubMed ID: 29208486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation and in vitro evaluation of coconut oil-core cationic nanocapsules intended for vaginal delivery of clotrimazole.
    Santos SS; Lorenzoni A; Pegoraro NS; Denardi LB; Alves SH; Schaffazick SR; Cruz L
    Colloids Surf B Biointerfaces; 2014 Apr; 116():270-6. PubMed ID: 24503350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.
    Wang FJ; Zhang D; Liu ZH; Wu WX; Bai HH; Dong HY
    Chin Med J (Engl); 2016 May; 129(10):1161-5. PubMed ID: 27174323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photodynamic therapy-mediated hypericin-loaded nanostructured lipid carriers against vulvovaginal candidiasis.
    Sato MR; Oshiro-Junior JA; Rodero CF; Boni FI; Araújo VHS; Bauab TM; Nicholas D; Callan JF; Chorilli M
    J Mycol Med; 2022 Nov; 32(4):101296. PubMed ID: 35660541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
    Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
    Khan F; Baqai R
    J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Miconazole loaded chitosan-based nanoparticles for local treatment of vulvovaginal candidiasis fungal infections.
    Amaral AC; Saavedra PHV; Oliveira Souza AC; de Melo MT; Tedesco AC; Morais PC; Soares Felipe MS; Bocca AL
    Colloids Surf B Biointerfaces; 2019 Feb; 174():409-415. PubMed ID: 30481701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
    Liu XP; Fan SR; Peng YT; Zhang HP
    J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and evaluation of N-naphthyl-N,O-succinyl chitosan micelles containing clotrimazole for oral candidiasis treatment.
    Tonglairoum P; Woraphatphadung T; Ngawhirunpat T; Rojanarata T; Akkaramongkolporn P; Sajomsang W; Opanasopit P
    Pharm Dev Technol; 2017 Mar; 22(2):184-190. PubMed ID: 27050629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.
    Nagashima M; Yamagishi Y; Mikamo H
    J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
    Adjapong G; Hale M; Garrill A
    Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syngonanthus nitens Bong. (Rhul.)-Loaded Nanostructured System for Vulvovaginal Candidiasis Treatment.
    Dos Santos Ramos MA; de Toledo LG; Calixto GM; Bonifácio BV; de Freitas Araújo MG; Dos Santos LC; de Almeida MT; Chorilli M; Bauab TM
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Miconazole-loaded nanoparticles coated with hyaluronic acid to treat vulvovaginal candidiasis.
    Teixeira ADR; Quaresma AV; Branquinho RT; Santos SLEN; Magalhães JT; Silva FHRD; Marques MBF; Moura SAL; Barboza APM; Araújo MGF; Silva GRD
    Eur J Pharm Sci; 2023 Sep; 188():106508. PubMed ID: 37379779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.
    Chew SY; Than LT
    Mycoses; 2016 May; 59(5):262-73. PubMed ID: 26765516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique database.
    Mårdh PA; Wågström J; Landgren M; Holmén J
    Infect Dis Obstet Gynecol; 2004 Jun; 12(2):91-7. PubMed ID: 15739823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
    Hacioglu M; Guzel CB; Savage PB; Tan ASB
    Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing the effectiveness of Salvia officinalis, clotrimazole and their combination on vulvovaginal candidiasis: A randomized, controlled clinical trial.
    Ahangari F; Farshbaf-Khalili A; Javadzadeh Y; Adibpour M; Sadeghzadeh Oskouei B
    J Obstet Gynaecol Res; 2019 Apr; 45(4):897-907. PubMed ID: 30663184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.